# Study to Investigate the Efficacy and Pharmacokinetic Profile of K-877-ER Compared to K-877-IR

> **NCT04447820** · PHASE2 · COMPLETED · sponsor: **Kowa Research Institute, Inc.** · enrollment: 96 (actual)

## Conditions studied

- Dyslipidemia

## Interventions

- **DRUG:** K-877-ER (Dose A)
- **DRUG:** K-877-ER (Dose B)
- **DRUG:** K-877-IR

## Key facts

- **NCT ID:** NCT04447820
- **Lead sponsor:** Kowa Research Institute, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-10
- **Primary completion:** 2020-12-03
- **Final completion:** 2020-12-03
- **Target enrollment:** 96 (ACTUAL)
- **Last updated:** 2023-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04447820

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04447820, "Study to Investigate the Efficacy and Pharmacokinetic Profile of K-877-ER Compared to K-877-IR". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04447820. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*